Damora Therapeutics Inc (DMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 74,253 | 163,582 | 85,333 | 0 | 0 |
| Marketable Securities | 36,081 | N/A | N/A | 0 | 0 |
| Receivables | N/A | N/A | 5,473 | 0 | 0 |
| TOTAL | $116,902 | $169,295 | $96,143 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 63 | N/A | N/A | N/A | N/A |
| Investments And Advances | 38,576 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 3,114 | 2,301 | 2,011 | 0 | 0 |
| TOTAL | $41,753 | $2,301 | $2,011 | $N/A | $N/A |
| Total Assets | $158,655 | $171,596 | $98,154 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,782 | 2,851 | 4,463 | 0 | 0 |
| Accrued Expenses | 3,758 | 2,715 | 3,818 | 0 | 0 |
| TOTAL | $5,540 | $5,566 | $8,281 | $0 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 544 | 541 | 589 | 0 | 0 |
| TOTAL | $544 | $541 | $589 | $N/A | $N/A |
| Total Liabilities | $6,084 | $6,107 | $8,870 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,010 | 1,010 | 1,010 | N/A | N/A |
| Retained earnings | -117,705 | -104,360 | -92,783 | 0 | 0 |
| Other shareholders' equity | 70 | 674 | 180,706 | 0 | 0 |
| TOTAL | $152,571 | $165,489 | $89,284 | $0 | $0 |
| Total Liabilities And Equity | $158,655 | $171,596 | $98,154 | $0 | $0 |